经蝶手术
医学
库欣病
生活质量(医疗保健)
多中心研究
梅德林
疾病
儿科
外科
内科学
垂体腺瘤
腺瘤
随机对照试验
政治学
护理部
法学
作者
Matthew C. Findlay,Sam Tenhoeve,Jeremiah A. Alt,Robert C. Rennert,William T. Couldwell,James Evans,Sarah Collopy,Won Kim,William Delery,Donato Pacione,Albert H. Kim,Julie Silverstein,Michael R. Chicoine,Paul A. Gardner,Lauren E. Rotman,Kevin C.J. Yuen,Garni Barkhoudarian,Juan C. Fernandez‐Miranda,Carolina Benjamin,Varun R. Kshettry
出处
期刊:Neurosurgery
[Lippincott Williams & Wilkins]
日期:2024-06-21
卷期号:95 (4): 761-769
被引量:4
标识
DOI:10.1227/neu.0000000000003042
摘要
Cushing disease (CD) affects mortality and quality of life along with limited long-term remission, underscoring the need to better identify recurrence risk. The identification of surgical or imaging predictors for CD remission after transsphenoidal surgery has yielded some inconsistent results and has been limited by single-center, single-surgeon, or meta-analyses studies. We sought to evaluate the multicenter Registry of Adenomas of the Pituitary and Related Disorders (RAPID) database of academic US pituitary centers to assess whether robust nonhormonal recurrence predictors could be elucidated.
科研通智能强力驱动
Strongly Powered by AbleSci AI